Brainstorm Cell (BCLI)
1.4500  -0.0600 (-3.97%)

Brainstorm Cell Therapeutics is a biotechnology company focused on developing innovative therapies aimed at treating neurodegenerative diseases and neurological conditions through the harnessing of stem cell technology. The company is particularly known for its research and development of treatments using its proprietary approach to generating cells that can potentially repair or regenerate damaged tissues in the central nervous system. By leveraging its expertise in cellular therapy, Brainstorm Cell aims to provide new hope for patients suffering from debilitating disorders. Through ongoing clinical trials and research initiatives, the company is committed to advancing its scientific discoveries into effective treatment options.

SummaryNewsPress ReleasesChartHistorical
Previous Close1.510
Open1.550
Bid1.400
Ask1.540
Day's Range1.420 - 1.630
52 Week Range1.050 - 11.89
Volume46,458
Market Cap8.27M
PE Ratio (TTM)0.4328
EPS (TTM)3.4
Dividend & YieldN/A (N/A)
1 Month Average Volume98,294

News & Press Releases

12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · September 27, 2024
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · September 16, 2024
BCLI Stock Earnings: Brainstorm Cell Misses EPS for Q2 2024investorplace.com
BCLI stock results show that Brainstorm Cell missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 14, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · June 14, 2024
BCLI Stock Earnings: Brainstorm Cell Reported Results for Q1 2024investorplace.com
Brainstorm Cell just reported results for the first quarter of 2024.
Via InvestorPlace · May 14, 2024
Brainstorm Cell: Q4 Earnings Insightsbenzinga.com
Via Benzinga · April 1, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 10, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · May 24, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesdayinvestorplace.com
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning!
Via InvestorPlace · May 1, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · April 30, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 9, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesdayinvestorplace.com
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
Via InvestorPlace · April 9, 2024
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.
Via Benzinga · April 9, 2024
BCLI Stock Earnings: Brainstorm Cell Beats EPS for Q4 2023investorplace.com
BCLI stock results show that Brainstorm Cell beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · April 1, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · April 1, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · March 25, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · March 20, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · February 21, 2024
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via Benzinga · March 25, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · February 19, 2024
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meetingbenzinga.com
BioRestorative Therapies (NASDAQ: BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and diabetes.
Via Benzinga · February 13, 2024
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales
Via Benzinga · January 30, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · January 22, 2024
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · January 12, 2024
BCLI DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - BCLI
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 2, 2024